Crinetics Pharmaceuticals (CRNX) EBT Margin (2017 - 2026)
Crinetics Pharmaceuticals' quarterly EBT Margin came in at 1189.81% in Q1 2026, up 2556116.0% year-on-year from N/an in Q1 2025, and up 40.23% quarter-over-quarter from 1990.5% in Q4 2025.
Crinetics Pharmaceuticals has reported EBT Margin for 10 years, with the latest figure at 1189.81% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 2556116.0% year-over-year to 1189.81%; the trailing twelve-month figure through Mar 2026 stood at 2745.57% (up 4041706.0% YoY), and the FY2025 full-year result was 6043.88%, up 2263158.0% from the prior year.
- EBT Margin for Q1 2026 stood at 1189.81%, up from 1990.5% in the prior quarter.
- The five-year high for EBT Margin was 1074.23% in Q1 2022, with the low at 90972.73% in Q3 2025.
- Average EBT Margin over 5 years is 15036.21%, with a median of 9400.75% recorded in 2022.
- Year-over-year, EBT Margin plunged 1640581 bps in 2025 and surged 2556116 bps in 2026.
- Tracing CRNX's EBT Margin over 5 years: stood at 6438.93% in 2022, then sank by 153 bps to 16302.89% in 2023, then slipped by 14 bps to 18556.89% in 2024, then surged by 89 bps to 1990.5% in 2025, then surged by 40 bps to 1189.81% in 2026.
- The last three EBT Margin figures came in at 1189.81% (Q1 2026), 1990.5% (Q4 2025), and 90972.73% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 18.99% |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn | -1,189.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,189.81% |
| Dec 31, 2025 | -1,990.50% |
| Sep 30, 2025 | -90,972.73% |
| Jun 30, 2025 | -11,217.94% |
| Mar 31, 2025 | -26,750.97% |
| Jun 30, 2024 | -18,556.89% |
| Mar 31, 2024 | -10,345.16% |
| Sep 30, 2023 | -16,302.89% |
| Jun 30, 2023 | -5,150.61% |
| Mar 31, 2023 | -1,714.82% |
| Dec 31, 2022 | -6,438.93% |
| Sep 30, 2022 | -9,160.26% |
| Jun 30, 2022 | -9,641.23% |
| Mar 31, 2022 | -1,074.23% |
| Dec 31, 2021 | -2,857.88% |
| Dec 31, 2020 | 30,616.90% |
| Mar 31, 2020 | -24,261.97% |
| Dec 31, 2019 | -4,535.51% |
| Sep 30, 2019 | -2,850.30% |
| Mar 31, 2019 | -2,461.58% |
| Dec 31, 2018 | -1,079.64% |
| Sep 30, 2018 | -1,375.18% |
| Jun 30, 2018 | -842.01% |
| Mar 31, 2018 | -1,235.75% |
| Dec 31, 2017 | -472.73% |
| Sep 30, 2017 | -370.31% |
| Jun 30, 2017 | -197.00% |